NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
1-(3-hexanoyl-2,4,6-trihydroxyphenyl)hexan-1-one
|
|
|
IUPAC Traditional name
|
1-(3-hexanoyl-2,4,6-trihydroxyphenyl)hexan-1-one
|
|
|
Synonyms
|
1,1′-(2,4,6-Trihydroxy-1,3-phenylene)bis-1-hexanone
|
2,4-(bis-1-ketohexyl)phloroglucinol
|
Hyp9
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
8.420199
|
H Acceptors
|
5
|
H Donor
|
3
|
LogD (pH = 5.5)
|
6.8458114
|
LogD (pH = 7.4)
|
6.8068833
|
Log P
|
6.8463287
|
Molar Refractivity
|
89.6661 cm3
|
Polarizability
|
34.36583 Å3
|
Polar Surface Area
|
94.83 Å2
|
Rotatable Bonds
|
10
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
H9791
|
Biochem/physiol Actions Hyperforin is the active ingredient in St. John′s Wort. It is used to treat depression, known to indirectly inhibit reuptake of serotonin and norepinephrine at the synapse, and recently discovered to exert its actions by directly activating TRPC6. TRPC6 is a member of the canonical transient receptor potential (TRPC) family of ion channels. DAG is the endogenous activator of this channel, and Hyperforin is the only known TRPC6-selective activator. Although it is broadly used, Hyperforin is chemically unstable. Efforts to find a stable but pharmacologically similar TRPC6 activator resulted in the discovery of Hyp9, a simplified phloroglucinol derivative. Like Hyperforin, Hyp9 inhibits serotonin reuptake and induces neurite outgrowth. It increases calcium entry into the cell and selectively increases current through TRPC6 channels. |
PATENTS
PATENTS
PubChem Patent
Google Patent